Literature DB >> 6259165

Purification and characterization of an apurinic/apyrimidinic endonuclease from HeLa cells.

C M Kane, S Linn.   

Abstract

An endodeoxyribonuclease from HeLa cells acting on apurinic/apyrimidinic (AP) sites has been purified to apparent homogeneity as judged by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. The presence of Triton X-100 was necessary throughout the purification for stabilization and stimulation of activity. The endonuclease has an apparent native molecular weight of 32,000 determined by molecular sieving and an apparent subunit molecular weight of 41,000 as judged by its electrophoretic mobility in SDS-polyacrylamide gels. The activity has an absolute requirement for Mg2+ or Mn2+ and a broad pH optimum between 6.7 and 9.0 with maximal activity near pH 7.5. The enzyme has no detectable exonuclease activity, nor any endonuclease activity on untreated duplex or single-stranded DNA. It is inhibited by adenine, hypoxanthine, adenosine, AMP, ADP-ribose, and NAD+, but it is unaffected by caffeine, the pyrimidine bases, ADP, ATP, or NADH. The use of a variety of damaged DNA substrates provided no indication that the enzyme acts on other than AP sites. The enzyme appears to cleave AP DNA so as to leave deoxyribose-5-phosphate at the 5' terminus and a 3'-OH at the 3' terminus; it also removes deoxyribose-5-phosphate from AP DNA which has deoxyribose at the 3' terminus. Specific antibody has been produced in rabbits which interacts only with a 41,000-dalton protein present in the purified enzyme (presumably the enzyme itself), as well as with partially purified AP endonuclease fractions from human placenta and fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259165

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Mismatch-specific thymine DNA glycosylase and DNA polymerase beta mediate the correction of G.T mispairs in nuclear extracts from human cells.

Authors:  K Wiebauer; J Jiricny
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 2.  Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis.

Authors:  Satya Narayan; Ritika Sharma
Journal:  Life Sci       Date:  2015-09-01       Impact factor: 5.037

3.  Escherichia coli mutY gene encodes an adenine glycosylase active on G-A mispairs.

Authors:  K G Au; S Clark; J H Miller; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Drosophila ribosomal protein PO contains apurinic/apyrimidinic endonuclease activity.

Authors:  A Yacoub; M R Kelley; W A Deutsch
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

5.  Apurinic endonuclease activity from wild-type and repair-deficient mei-9 Drosophila ovaries.

Authors:  S Venugopal; S N Guzder; W A Deutsch
Journal:  Mol Gen Genet       Date:  1990-05

6.  Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants.

Authors:  C N Robson; I D Hickson
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

Review 7.  A novel function of adenomatous polyposis coli (APC) in regulating DNA repair.

Authors:  Aruna S Jaiswal; Satya Narayan
Journal:  Cancer Lett       Date:  2008-07-26       Impact factor: 8.679

8.  Drosophila AP3, a presumptive DNA repair protein, is homologous to human ribosomal associated protein P0.

Authors:  D T Grabowski; W A Deutsch; D Derda; M R Kelley
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

9.  APE1 is the major 3'-phosphoglycolate activity in human cell extracts.

Authors:  Jason L Parsons; Irina I Dianova; Grigory L Dianov
Journal:  Nucleic Acids Res       Date:  2004-07-06       Impact factor: 16.971

10.  A Drosophila ribosomal protein contains 8-oxoguanine and abasic site DNA repair activities.

Authors:  A Yacoub; L Augeri; M R Kelley; P W Doetsch; W A Deutsch
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.